| Sudeep Pharma Ltd |
|
|
| Initial public offer of 15,092,749 equity shares of face value of Re.1/- each ("equity shares") of Sudeep Pharma Limited ("company") for cash at a price of Rs.593/- per equity share (including a share premium of Rs.592/- per equity share) ("offer price") aggregating to Rs.895.00 crores comprising a fresh issue of 1,602,023 equity shares of face value of Re.1/- aggregating to Rs. 95.00 crores by the company ("fresh issue") and an offer for sale of 13,490,726 equity shares of face value of Re.1/- aggregating to Rs.800.00 crores ("offered shares") by the selling shareholders, consisting of 3,567,670 equity shares of face value of Re.1/- aggregating to Rs.211.56 crores by SujitJjaysukh Bhayani, 8,418,856 equity shares of face value of Re.1/- aggregating to Rs. 499.24 crores by Sujeet Jaysukh Bhayani HUF, 750,000 equity shares of face value of Re.1/- aggregating to Rs.44.48 crores by Shanil Sujit Bhayani and 754,200 equity shares of face value of Re.1/- aggregating to Rs.44.72 crores by Avani Sujit Bhayani (collectively "the selling shareholders") and such equity shares offered by the selling shareholders ("offer for sale", and together with the fresh issue, the "offer").
Price Band: Rs. 593/- for equity share of face value of Rs. 1 each.
The floor price is 593 times times the face value times of the face value of the equity shares.
Bids can made for a minimum of 25 equity shares and in multiples of 25 equity shares thereafter. |
| Issue |
Money Payable On |
| Opened On |
Closed On |
Offer Price |
Application |
| 21-Nov-25 |
25-Nov-25 |
₹ 593.00 |
₹ 593.00 |
| Minimum Application for shares in Nos :25 Further Multiples of :25 |
| |
|
Lead Managers to the Issue |
| Project Cost |
₹ 88.48 Cr |
| ICICI Securities Limited | | IIFL Capital Services Limited |
|
| Project Financed through Current Offer |
₹ 895.00 Cr |
|
| Post Issue Equity Share Capital |
₹ 11.29 Cr |
|
| Face Value |
₹ 1 |
|
|